Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Interest Expenses: 2012-2024

Historic Interest Expenses for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to $8,529.

  • Sunshine Biopharma's Interest Expenses fell 71.67% to $8,529 in Q4 2024 from the same period last year, while for Dec 2024 it was $88,065, marking a year-over-year decrease of 22.10%. This contributed to the annual value of $8,774 for FY2024, which is 93.61% down from last year.
  • Per Sunshine Biopharma's latest filing, its Interest Expenses stood at $8,529 for Q4 2024, which was up 3,381.22% from $245 recorded in Q2 2024.
  • In the past 5 years, Sunshine Biopharma's Interest Expenses ranged from a high of $195,630 in Q2 2021 and a low of $2 during Q3 2022.
  • In the last 3 years, Sunshine Biopharma's Interest Expenses had a median value of $19,705 in 2022 and averaged $21,041.
  • As far as peak fluctuations go, Sunshine Biopharma's Interest Expenses crashed by 100.00% in 2022, and later spiked by 1,926,250.00% in 2023.
  • Sunshine Biopharma's Interest Expenses (Quarterly) stood at $105,436 in 2020, then slumped by 65.26% to $36,630 in 2021, then fell by 27.53% to $26,546 in 2022, then grew by 13.43% to $30,110 in 2023, then tumbled by 71.67% to $8,529 in 2024.
  • Its Interest Expenses stands at $8,529 for Q4 2024, versus $245 for Q2 2024 and $49,181 for Q1 2024.